Small Financial Incentives to Promote Smoking Cessation
PrevailII
2 other identifiers
interventional
320
1 country
1
Brief Summary
The primary objectives of this study are 1) to evaluate the longer-term impact of an adjunctive, low-cost financial incentives intervention (relative to standard care) on smoking abstinence rates among socioeconomically disadvantaged individuals participating in a clinic-based smoking cessation program and 2) to identify treatment mechanisms and contextual factors associated with cessation outcomes among intervention participants using both traditional and ecological momentary assessment approaches. Those randomized to the financial incentives intervention will have the opportunity to earn small gift cards for biochemically-verified abstinence through 12 weeks post-quit. We hypothesize that individuals who are randomly assigned to the adjunctive CM intervention will have significantly higher rates of biochemically-verified abstinence at the 26-week post-quit follow-up than those assigned to Usual Care. In addition, we hypothesize that several factors related to socioeconomic disadvantage will be directly associated with non-abstinence, especially greater stress/adversity, limited psychosocial resources, greater negative affect, greater nicotine dependence, and poorer treatment adherence. The primary study endpoints will include self-reported tobacco use/abstinence, expired carbon monoxide (CO) levels (i.e., the amount of carbon monoxide present in an individual's breath when they breathe out), and saliva cotinine levels at 26 weeks post-quit attempt, though smoking status will be assessed at all visits. Traditional questionnaire measurement and ecological momentary assessment (EMA) will be utilized to measure potential treatment mechanisms including motivation, self-efficacy, and treatment adherence. Other variables including stress/adversity, psychosocial resources, negative affect, nicotine dependence, and treatment adherence will also be assessed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2017
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 7, 2016
CompletedFirst Posted
Study publicly available on registry
April 14, 2016
CompletedStudy Start
First participant enrolled
January 30, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 8, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
February 8, 2022
CompletedResults Posted
Study results publicly available
April 20, 2023
CompletedMay 13, 2026
April 1, 2026
5 years
April 7, 2016
March 28, 2023
April 30, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Biochemically-verified Smoking Cessation
The primary outcome measure is carbon monoxide (CO)-verified 7-day point prevalence abstinence at 26 weeks post-quit (intent-to-treat; missing=smoking).
26 weeks post-quit
Secondary Outcomes (1)
Biochemically-verified Smoking Cessation
12 weeks post-quit
Study Arms (2)
Standard Care + Financial Incentives
EXPERIMENTALParticipants randomized to Standard Care + Financial Incentives for Abstinence will be offered smoking cessation counseling and pharmacotherapy (standard care) and they will have the opportunity to earn small gift cards for biochemically-verified abstinence through 12 weeks post-quit. The amount of the gift cards will escalate each week from the quit date through 4 weeks post-quit with continuous abstinence. Participants who are non-abstinent at any visit may earn incentives for abstinence at the next visit, but the amount will reset to the starting level. Participants may additionally earn an additional gift card for abstinence at the 8 and 12 weeks post-quit visits.
Standard Care
ACTIVE COMPARATORParticipants randomized to Standard Care will be offered weekly smoking cessation counseling and pharmacotherapy.
Interventions
Tobacco cessation counseling plus pharmacotherapy and financial incentives for quitting.
Eligibility Criteria
You may qualify if:
- are currently uninsured or receiving Medicaid benefits
- earn a score ≥ 4 on the REALM indicating \> 6th grade English literacy level
- are willing to quit smoking 7 days from their first visit
- are ≥ 18 years of age
- have an expired CO level ≥ 8 ppm suggestive of current smoking
- are currently smoking ≥ 5 cigarettes per day
- are willing and able to attend 9 study visits.
You may not qualify if:
- are unwilling to quit smoking 7 days from their first visit
- have already quit smoking
- earn a score \<4 on the REALM indicating \< 7th grade literacy level
- produce an expired CO level \< 8 ppm
- are currently smoking \< 5 cigarettes per day
- are unwilling or unable to attend study visits
- are \< 18 years of age
- are not uninsured or receiving Medicaid benefits
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Oklahomalead
- National Cancer Institute (NCI)collaborator
Study Sites (1)
TSET Health Promotion Research Center
Oklahoma City, Oklahoma, 73104, United States
Related Publications (3)
Liang M, Koslovsky MD, Hebert ET, Kendzor DE, Businelle MS, Vannucci M. Bayesian continuous-time hidden Markov models with covariate selection for intensive longitudinal data with measurement error. Psychol Methods. 2023 Aug;28(4):880-894. doi: 10.1037/met0000433. Epub 2021 Dec 20.
PMID: 34928674RESULTKendzor DE, Businelle MS, Frank-Pearce SG, Waring JJC, Chen S, Hebert ET, Swartz MD, Alexander AC, Sifat MS, Boozary LK, Wetter DW. Financial Incentives for Smoking Cessation Among Socioeconomically Disadvantaged Adults: A Randomized Clinical Trial. JAMA Netw Open. 2024 Jul 1;7(7):e2418821. doi: 10.1001/jamanetworkopen.2024.18821.
PMID: 38954415RESULTBoozary LK, Chen M, Frank-Pearce SG, Hebert ET, Chen S, Alexander AC, Ogunsanya ME, Sifat MS, Oliver JA, Businelle MS, Kendzor DE. Discrimination experiences are associated with same-day and next-day smoking among adults with low socio-economic status trying to quit: A secondary analysis of data from a randomized clinical trial. Addiction. 2026 Apr 30. doi: 10.1111/add.70419. Online ahead of print.
PMID: 42057652RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Limitations and Caveats
Study enrollment occurred from 2017-2021. As a result, a total of 146 (45.6%) of participants received treatment and/or had scheduled study assessments following the onset of the COVID-19 pandemic (in March 2020). The pandemic may have affected smoking cessation outcomes and other study variables, including retention and study follow-up rates through a variety of influences (e.g., institutional restrictions on research, financial, stress/mental health).
Results Point of Contact
- Title
- Dr. Darla Kendzor
- Organization
- The University of Oklahoma Health Sciences Center
Study Officials
- PRINCIPAL INVESTIGATOR
Darla E. Kendzor, Ph.D.
University of Oklahoma Health Campus
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 7, 2016
First Posted
April 14, 2016
Study Start
January 30, 2017
Primary Completion
February 8, 2022
Study Completion
February 8, 2022
Last Updated
May 13, 2026
Results First Posted
April 20, 2023
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share